Celldex Therapeutics reported $121K in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 12.54B 474M Mar/2026
Agenus USD 34.2M 4.61M Dec/2025
Amgen USD 6.89B 415M Dec/2025
Bristol-Myers Squibb USD 8.41B 381M Dec/2025
Celldex Therapeutics USD 121K 609K Dec/2025
Glaxosmithkline GBP 8.75B 2.92B Sep/2025
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Pfizer USD 12.28B 8.74B Dec/2025
Rigel Pharmaceuticals USD 28.49M 7.01M Jun/2024
Roche Holding CHF 22.09B 10.04B Dec/2025